These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 16061590

  • 1. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study.
    Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P.
    Pediatrics; 2005 Aug; 116(2):360-9. PubMed ID: 16061590
    [Abstract] [Full Text] [Related]

  • 2. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
    Zeiger RS, Bird SR, Kaplan MS, Schatz M, Pearlman DS, Orav EJ, Hustad CM, Edelman JM.
    Am J Med; 2005 Jun; 118(6):649-57. PubMed ID: 15922697
    [Abstract] [Full Text] [Related]

  • 3. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening A, Haahtela T, Holgate ST, Picado C, Leff JA.
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 5. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM.
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [Abstract] [Full Text] [Related]

  • 6. "Real-world" effectiveness of daily controller medicine in children with mild persistent asthma.
    Bukstein DA, Luskin AT, Bernstein A.
    Ann Allergy Asthma Immunol; 2003 May; 90(5):543-9. PubMed ID: 12775136
    [Abstract] [Full Text] [Related]

  • 7. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM, Edelman JM.
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
    [Abstract] [Full Text] [Related]

  • 8. Adherence with montelukast or fluticasone in a long-term clinical trial: results from the mild asthma montelukast versus inhaled corticosteroid trial.
    Rand C, Bilderback A, Schiller K, Edelman JM, Hustad CM, Zeiger RS, MIAMI Study Research Group.
    J Allergy Clin Immunol; 2007 Apr; 119(4):916-23. PubMed ID: 17349681
    [Abstract] [Full Text] [Related]

  • 9. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial.
    Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T, Holgate ST, Picado C, Menten J, Dass SB, Leff JA, Polos PG.
    BMJ; 2003 Oct 18; 327(7420):891. PubMed ID: 14563743
    [Abstract] [Full Text] [Related]

  • 10. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG, Rodrigues MT, Zamel N, Chapman KR.
    Respir Med; 2009 Feb 18; 103(2):296-300. PubMed ID: 18805684
    [Abstract] [Full Text] [Related]

  • 11. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Dec 18; 93(6):581-8. PubMed ID: 15609769
    [Abstract] [Full Text] [Related]

  • 12. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.
    Fogel RB, Rosario N, Aristizabal G, Loeys T, Noonan G, Gaile S, Smugar SS, Polos PG.
    Ann Allergy Asthma Immunol; 2010 Jun 18; 104(6):511-7. PubMed ID: 20568384
    [Abstract] [Full Text] [Related]

  • 13. Review of recent results of montelukast use as a monotherapy in children with mild asthma.
    Wahn U, Dass SB.
    Clin Ther; 2008 Jun 18; 30 Spec No():1026-35. PubMed ID: 18640477
    [Abstract] [Full Text] [Related]

  • 14. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
    Jayaram L, Pizzichini E, Lemière C, Man SF, Cartier A, Hargreave FE, Pizzichini MM.
    Thorax; 2005 Feb 18; 60(2):100-5. PubMed ID: 15681495
    [Abstract] [Full Text] [Related]

  • 15. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
    Eur Ann Allergy Clin Immunol; 2003 Nov 18; 35(9):356-62. PubMed ID: 14716965
    [Abstract] [Full Text] [Related]

  • 16. High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma.
    Schuh S, Dick PT, Stephens D, Hartley M, Khaikin S, Rodrigues L, Coates AL.
    Pediatrics; 2006 Aug 18; 118(2):644-50. PubMed ID: 16882819
    [Abstract] [Full Text] [Related]

  • 17. Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial.
    Sorkness CA, Lemanske RF, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
    J Allergy Clin Immunol; 2007 Jan 18; 119(1):64-72. PubMed ID: 17140647
    [Abstract] [Full Text] [Related]

  • 18. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
    O'Sullivan S, Akveld M, Burke CM, Poulter LW.
    Am J Respir Crit Care Med; 2003 Mar 01; 167(5):745-50. PubMed ID: 12480610
    [Abstract] [Full Text] [Related]

  • 19. Randomized comparison of strategies for reducing treatment in mild persistent asthma.
    American Lung Association Asthma Clinical Research CentersWake Forest University, Winston-Salem, NC, USA., Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ, Wise RA.
    N Engl J Med; 2007 May 17; 356(20):2027-39. PubMed ID: 17507702
    [Abstract] [Full Text] [Related]

  • 20. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma.
    Zeiger RS, Szefler SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM, Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute.
    J Allergy Clin Immunol; 2006 Jan 17; 117(1):45-52. PubMed ID: 16387583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.